{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:41:28Z","timestamp":1757616088010,"version":"3.44.0"},"reference-count":5,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Fam Plann Reprod Health Care"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1136\/jfprhc-2013-100693","type":"journal-article","created":{"date-parts":[[2013,9,24]],"date-time":"2013-09-24T00:30:53Z","timestamp":1379982653000},"page":"304.1-304","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Comment on \u2018Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism\u2019"],"prefix":"10.1136","volume":"39","author":[{"given":"Mishka","family":"Terplan","sequence":"first","affiliation":[{"name":"National Research Center for Women & Families, Washington, DC, USA; mt@center4research.org"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2013,9,23]]},"reference":[{"key":"2025090510115633000_39.4.304.1","doi-asserted-by":"crossref","unstructured":"Blitzer J Amy JJ Beerhuizen R . Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism. J Fam Plann Reprod Health Care 2013;39:156\u2013159.","DOI":"10.1136\/jfprhc-2013-100710"},{"key":"2025090510115633000_39.4.304.2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users","volume":"1","author":"Sidney","year":"2013","journal-title":"Contraception"},{"key":"2025090510115633000_39.4.304.3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2105\/AJPH.2012.300706","article-title":"How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960","volume":"8","author":"Watkins","year":"2012","journal-title":"Am J Public Health"},{"key":"2025090510115633000_39.4.304.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5621"},{"key":"2025090510115633000_39.4.304.5","doi-asserted-by":"crossref","first-page":"e1000425","DOI":"10.1371\/journal.pmed.1000425","article-title":"Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles","volume":"3","author":"Fugh-Berman","year":"2011","journal-title":"PLoS Med"}],"container-title":["Journal of Family Planning and Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jfprhc-2013-100693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:16:00Z","timestamp":1757092560000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/jfprhc-2013-100693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,23]]},"references-count":5,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,9,23]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.1136\/jfprhc-2013-100693"],"URL":"https:\/\/doi.org\/10.1136\/jfprhc-2013-100693","relation":{},"ISSN":["1471-1893","2045-2098"],"issn-type":[{"type":"print","value":"1471-1893"},{"type":"electronic","value":"2045-2098"}],"subject":[],"published":{"date-parts":[[2013,9,23]]}}}